Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: Comparison with radiation therapy alone

Gynecologic Oncology

Volumn 103, Issue 1, 2006, Pages 94-99

  Ohno, Tatsuya ^a   Kato, Shingo ^a   Wakatsuki, Masaru ^a   Noda, Shin ei ^a   Murakami, Chiemi ^a   Nakamura, Misako ^a   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Cervical cancer; Chemoradiation therapy; Cisplatin; Toxicity

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; METOCLOPRAMIDE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LOW DRUG DOSE; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; UTERINE CERVIX CANCER; WEIGHT REDUCTION;

AGE FACTORS; AGED; ANOREXIA; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKOPENIA; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; WEIGHT LOSS;

EID: 33748749545     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.048     Document Type: Article

References (23)

1. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
2. Kirwan J.M., Symonds P., Green J.A., et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother. Oncol. 68 (2003) 217-226
3. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 (1999) 1154-1161
4. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
5. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol. 20 (2002) 966-972
6. Creasman W.T. New gynecologic cancer staging. Gynecol. Oncol. 58 (1995) 157-158
7. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 (1999) 1339-1348
8. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 (1999) 1137-1143
9. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 (2000) 1606-1613
10. Martin M. The severity and pattern of emesis following different cytotoxic agents. Oncology 53 Suppl. 1 (1996) 26-31
11. ASHP. Therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am. J. Health Syst. Pharm. 56 (1999) 729-764
12. Gralla R.J., Osoba D., Kris M.G., et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J. Clin. Oncol. 17 (1999) 2971-2994
13. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC). Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Ann. Oncol. 9 (1998) 811-819
14. Lindley C.M., Hirsch J.D., O'Neill C.V., et al. Quality of life consequences of chemotherapy-induced emesis. Qual. Life Res. 1 (1992) 331-340
15. Liaw C.C., Wang C.H., Chang H.K., et al. Control of cisplatin-induced emesis with intravenous ondansetron plus intravenous dexamethasone: a crossover study of triple 8-mg dose of ondansetron. Am. J. Clin. Oncol. 23 (2000) 253-257
16. Handberg J., Wessel V., Larsen L., et al. Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy. Support Care Cancer 6 (1998) 63-67
17. Paccagnella A., Favaretto A., Oniga F., et al. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer 43 (2004) 83-91
18. Mishler J.M., and Emerson P.M. Development of neutrophilia by serially increasing doses of dexamethasone. Br. J. Haematol. 36 (1977) 249-257
19. Patel D.A., Barnholtz-Sloan J.S., Patel M.K., et al. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: Analysis of Surveillance, Epidemiology, and End Results data. Gynecol. Oncol. 97 (2005) 550-558
20. Eifel P.J., Jhingran A., Bodurka D.C., et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J. Clin. Oncol. 20 (2002) 3651-3657
21. Ma B., Yeo W., Hui P., et al. Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer: a retrospective review of Chinese patients and comparison with an historic Western series. Radiother. Oncol. 62 (2002) 185-189
22. Millward M.J., Boyer M.J., Lehnert M., et al. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann. Oncol. 14 (2003) 449-454
23. Mitsuhashi A., Uno T., Tanaka N., et al. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma. Gynecol. Oncol. 96 (2005) 194-197